Evidence map›Paper›PMID 19935662›Full record

ArticleNature genetics2009

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.

Steven A McCarroll, James E Bradner, Hannu Turpeinen, Liisa Volin, Paul J Martin, Shannon D Chilewski, Joseph H Antin, Stephanie J Lee, Tapani Ruutu, Barry Storer and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Novel Aspects of Immunogenetics and Post-Transplant Events in Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Non-HLA donor-recipient mismatches in kidney transplantation-A stone left unturned.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Review
  15. Genomic Mismatch atThe New England journal of medicine · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Integrative omics for health and disease.Nature reviews. Genetics · 2018
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 3 countries.

Steven A McCarrollDepartment of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. mccarroll@genetics.med.harvard.edu
James E Bradner
Hannu Turpeinen
Liisa Volin
Paul J Martin
Shannon D Chilewski
Joseph H Antin
Stephanie J Lee
Tapani Ruutu
Barry Storer
Edus H Warren
Bo Zhang
Lue Ping Zhao
David Ginsburg
Robert J Soiffer
Jukka Partanen
John A Hansen
Jerome Ritz
Aarno Palotie
David Altshuler
Fred Hutch Cancer Center · USHarvard University · USBroad Institute · USFinnish Red Cross · FIMassachusetts General Hospital · USDana-Farber Cancer Institute · USHelsinki University Hospital · FISeattle University · USUniversity of Helsinki · FIUniversity of Michigan–Ann Arbor · USUniversity of Washington · US

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Evan Newell · 1985 to 2026
$128.4M
TRANSPLANTATION IMMUNOLOGYP01AI033484 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 1992 to 2013
$13.1M
Novel Approaches to GHVD PreventionP01HL070149 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI ANTIN, JOSEPH H · 2003 to 2007
$10.2M
Reconstitution of Regulatory T Cells after Allogeneic Stem Cell TransplantationU19AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SOIFFER, ROBERT JON · 2005 to 2010
$9.0M
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATIONP01AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RITZ, JEROME · 1990 to 2003
$4.5M
Whole Genome Association Analysis of Hematopoietic Cell Transplant OutcomeR01HL087690 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 2006 to 2008
$4.1M
NCI NIH HHS CA18029NCI NIH HHS P01 CA018029NHLBI NIH HHS HL087690NHLBI NIH HHS P01 HL070149NHLBI NIH HHS R01 HL087690NIAID NIH HHS AI29530NIAID NIH HHS AI33484NIAID NIH HHS P01 AI029530NIAID NIH HHS P01 AI033484NIAID NIH HHS U19 AI029530PHS HHS HA070149
6 · The paper itself

Abstract

Transplantation and pregnancy, in which two diploid genomes reside in one body, can each lead to diseases in which immune cells from one individual target antigens encoded in the other's genome. One such disease, graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT, or bone marrow transplant), is common even after transplants between HLA-identical siblings, indicating that cryptic histocompatibility loci exist outside the HLA locus. The immune system of an individual whose genome is homozygous for a gene deletion could recognize epitopes encoded by that gene as alloantigens. Analyzing common gene deletions in three HSCT cohorts (1,345 HLA-identical sibling donor-recipient pairs), we found that risk of acute GVHD was greater (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.4-4.6) when donor and recipient were mismatched for homozygous deletion of UGT2B17, a gene expressed in GVHD-affected tissues and giving rise to multiple histocompatibility antigens. Human genome structural variation merits investigation as a potential mechanism in diseases of alloimmunity.

Indexed as

Gene DeletionPolymorphism, GeneticBone Marrow TransplantationCohort StudiesFemaleGenome, HumanGlucuronosyltransferaseGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHLA AntigensHumansMaleMinor Histocompatibility AntigensGlucuronosyltransferaseHLA AntigensMinor Histocompatibility AntigensUGT2B17 protein, human

Identifiers

PMID19935662
PMCPMC2804745
OpenAlexW1963556044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.